Pandemic Preparedness Funding Exposed: Is the Industry Built on Fear?
Pandemic preparedness funding has grown into a $30–40 billion annual industry—ten times the entire WHO operating budget. Dr. David Bell, a former WHO physician now leading the REPPARE Project at the University of Leeds, has spent years reviewing the data behind these investments. His conclusion is troubling: the money is not flowing toward the world’s deadliest diseases. Instead, it is being channeled through public-private partnerships that serve pharmaceutical shareholders, institutional bureaucracies, and fear-driven narratives—not the populations most in need.
Table of Contents
The Rise of Pandemic Preparedness Funding: Follow the Money
WHO Pandemic Agreement: A New Financial Architecture
The pandemic preparedness narrative has reached fever pitch. The World Bank and WHO speak of “existential threats” requiring $30-40 billion annually—ten times WHO’s current total budget. In May 2025, the WHO Pandemic Agreement was formally adopted after three years of negotiation, cementing this new financial architecture.
But here’s what most people don’t know: WHO’s funding structure has fundamentally changed. Bell explains that 80% of WHO funding is now earmarked by specific donors for specific projects—a radical departure from the pooled country contributions that once gave the organization independence.
Gates Foundation and the Global Health Funding Machine
The Gates Foundation has become WHO’s largest single funder, surpassing even the United States following America’s announced withdrawal in 2025. Between 2000 and 2024, the Foundation donated $5.5 billion to WHO—with over 50% directed toward vaccines and polio programs.
As Bell notes with measured concern: “A company can only participate significantly in a public-private partnership if they think they’ll make money out of it.” This isn’t conspiracy—it’s basic economics. When pharmaceutical representatives sit on boards deciding how to spend public money, they fulfill their fiduciary duty to shareholders, not global health needs.
REPPARE Project: What the Evidence Actually Shows
WHO’s Priority Disease List Under the Microscope
Bell’s team scrutinized WHO’s R&D Blueprint—the list of diseases supposedly threatening humanity. The findings are remarkable:
- Lassa fever: ~5,000 deaths annually, confined to West Africa
- Ebola: One outbreak exceeding 10,000 deaths in recorded history
- SARS/MERS: ~750-800 deaths each, total
- Zika: Questionable causal link to microcephaly; problem has essentially disappeared
- Disease X: A theoretical pathogen that doesn’t exist
“There is nothing on that list that would logically cause you much concern,” Bell states. “Infectious disease deaths have been declining for a century.”
The COVID Data Inflation Scandal
Perhaps REPPARE’s most explosive finding concerns how COVID deaths are being counted for posterity. The Institute for Health Metrics and Evaluation (IHME)—funded by the Gates Foundation and considered the “gold standard” for disease burden data—has created models that systematically inflate COVID deaths while minimizing collateral damage from lockdowns and vaccines.
Their methodology assumes:
- Masks are “incredibly effective” (based on two questionable studies)
- Vaccines maintain 78-97% efficacy (far higher than manufacturers now claim)
- Natural immunity is inferior to vaccination (contradicting CDC data)
Using these assumptions, IHME converts the 15.9 million excess deaths during 2020-2021 into predominantly COVID deaths, particularly in African nations with low vaccination rates. As Bell warns: “We’re building a false history. Someday people will believe these numbers are real.”
Why Pandemic Preparedness Funding Doesn’t Fix Real Health Crises
Pandemic Preparedness as Revenue Stream
Bell doesn’t speak in conspiratorial whispers. He speaks with the resignation of someone who understands bureaucratic incentives:
“If you’re running a research lab, your main concern is making sure your staff don’t get sacked because you run out of money. If there’s $200 million earmarked for Zika vaccine research, you’ll work on Zika—not because we need it, but because the funding is there.”
The same logic applies throughout the system:
- WHO officials protect their Geneva lifestyles
- Research institutions chase available grants
- Pharmaceutical companies maximize shareholder returns
- Public-private partnerships like GAVI and CEPI direct taxpayer money toward vaccine sales
The Pandemic Fund and Global Health Security
The World Bank’s Pandemic Fund, established in 2022, has awarded $885 million in grants, catalyzing over $6 billion in total resources across 75 countries. While proponents celebrate this investment in global health security, critics like Bell ask: investment in what, exactly?
When malaria kills far more people annually than any disease on WHO’s priority list, when tuberculosis and HIV remain major killers, when basic sanitation would prevent millions of deaths—why are we directing resources toward theoretical pandemics?
Academic Capture: When Health Science Becomes Marketing
Bell is candid about the systemic problem: “Science has become marketing. Almost all nutrition research is funded by food companies. Almost all health research is funded by pharmaceutical ones. You get the results the sponsors want.”
The Neil Ferguson example is instructive. His Imperial College models predicted 500,000 UK deaths and 3 million US deaths from COVID—projections that justified lockdowns and eventually vaccine mandates. At the same time, Ferguson co-authored a Lancet paper showing almost no one under 65 died from COVID.
“Did he publish contradictory data?” one might ask. Yes. “Did it matter?” Apparently not when funding comes from interested parties.
Climate Change: The Perfect Partner Narrative
The WHO now officially claims climate change is “driving” malaria increases, despite evidence pointing to drug resistance, insecticide resistance, poverty, and civil war. Meanwhile, malaria is being successfully eliminated in temperate countries—exactly where climate warming should theoretically have the greatest impact.
As Bell observes: “If you’re doing vaccines, you will work on Zika not because we need a Zika vaccine but because there is $200 million sitting there waiting.”
The same dynamic applies to climate-pandemic linkages. Once you establish climate change as an amplifier of infectious disease risk, you unlock additional funding streams. The science becomes secondary to the narrative that unlocks resources.
The Path Forward: Restoring Integrity to Global Health Funding
Why REPPARE Matters
Bell remains guardedly hopeful, citing universities like Leeds that still “permit integrity” and organizations like Brownstone Institute that fund independent research without demanding predetermined outcomes.
The REPPARE Project’s methodology is simple but powerful: examine the evidence that institutions like WHO, World Bank, and G20 use to justify their claims. Don’t accept consensus. Don’t defer to authority. Check the citations.
What they’ve found repeatedly: institutional claims contradict their own cited evidence.
Real Threats Left Behind While Pandemic Budgets Balloon
While billions flow toward pandemic preparedness, the actual killers receive inadequate attention:
- Malaria: Hundreds of thousands of deaths annually
- Tuberculosis: Major ongoing burden
- Malnutrition: Preventable deaths in the millions
- Unsafe water and sanitation: Foundational health determinant
- Non-communicable diseases: 74% of global deaths
“We still have major problems in real health,” Bell emphasizes, “and billions are wasted chasing phantoms.”
Conclusion: Admitting the Problem Before Finding the Answer
Dr. David Bell’s message is both sobering and essential: we have to start admitting the problem before we can find the answer.
The pandemic industry has created a self-reinforcing cycle where:
- Inflated threat assessments generate funding
- Funding flows to well-connected organizations
- Those organizations produce research supporting the narrative
- The research becomes “authoritative data”
- The cycle repeats, growing each iteration
Breaking this cycle requires what Bell and REPPARE are doing: meticulous evidence review, intellectual honesty, and the courage to challenge powerful institutions.
As Bell concludes: “The incentives are wrong. The system rewards fear.” Until we realign incentives toward actual health outcomes rather than theoretical catastrophes, global health will remain captured by profit and politics.
The question isn’t whether another pandemic will come. The question is whether we’ll use public resources to address real health needs—or continue feeding an industry built on manufactured fear.
FAQ’s
What is pandemic preparedness funding?
Pandemic preparedness funding refers to the financial resources allocated by governments, international institutions, and private donors to prevent, detect, and respond to infectious disease outbreaks before they become global crises. In recent years, this funding has grown dramatically — the World Bank and WHO now call for $30–40 billion annually to be directed toward pandemic preparedness infrastructure, surveillance systems, and vaccine development programs. Critics, including researchers at the REPPARE Project, argue that pandemic preparedness funding is increasingly misallocated toward theoretical disease threats and pharmaceutical-aligned priorities, while proven killers like malaria, tuberculosis, and unsafe water — which claim millions of lives every year — remain chronically underfunded.
Who controls WHO’s pandemic budget?
WHO’s pandemic budget is no longer controlled primarily by member states. Today, approximately 80% of WHO’s funding is earmarked by specific donors for specific projects — meaning donors, not elected governments, effectively set the agenda. The Gates Foundation has become WHO’s single largest funder, having contributed $5.5 billion between 2000 and 2024, with over half directed toward vaccines and polio programs. Following the United States’ announced withdrawal in 2025, this concentration of influence has grown even more pronounced. The May 2025 WHO Pandemic Agreement further cemented this new financial architecture, raising serious questions about whose interests global pandemic preparedness funding ultimately serves.
What is the REPPARE Project?
The REPPARE Project — short for Rethinking Evidence, Policy, and Pandemic Response Evaluation — is an independent research initiative based at the University of Leeds. Led by Dr. David Bell, a physician and former WHO specialist in tropical medicine, and Professor Garrett Brown, Chair of Global Health Policy, REPPARE conducts forensic reviews of the evidence used by institutions like the WHO, World Bank, and G20 to justify pandemic preparedness funding decisions. Their findings have repeatedly shown that institutional claims often contradict the very sources they cite — including inflated COVID death counts, overstated disease risks, and systematic undercounting of lockdown-related harms. REPPARE is supported by the Brownstone Institute and operates with full editorial independence.
Key Takeaways
✓ Pandemic preparedness funding has grown to $30-40 billion annually, 10x WHO’s total budget ✓ Gates Foundation is now WHO’s largest single funder, directing 50%+ toward vaccines ✓ WHO’s priority disease list contains no pathogen that has killed more than a few thousand people ✓ Global burden of disease data is systematically inflating COVID deaths while minimizing lockdown harms ✓ Public-private partnerships direct taxpayer money toward pharmaceutical profits ✓ The REPPARE Project provides independent evidence review of pandemic industry claims ✓ Real health threats (malaria, TB, sanitation) remain underfunded while theoretical pandemics absorb resources
About REPPARE and Dr. David Bell
The REPPARE Project (Rethinking Evidence, Policy, and Pandemic Response Evaluation) operates from the University of Leeds, providing independent analysis of pandemic preparedness policies and claims. Dr. David Bell, a physician specializing in tropical medicine with extensive WHO experience, leads the evidence review alongside Professor Garrett Brown, Chair of Global Health Policy at Leeds. Their work is supported by Brownstone Institute and conducted with complete independence—a rarity in today’s funding environment where research outcomes are often predetermined by donor interests.
Discover more from Randy Bock MD PC
Subscribe to get the latest posts sent to your email.
